{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:58:17Z","timestamp":1781135897321,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05895-6","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:09:27Z","timestamp":1777122567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical utility of the HFA\u2013ICOS risk proforma for predicting heart failure hospitalization in a real-world cohort of multiple myeloma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Mei Han","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Yin","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Lun","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Saliangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Yuen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Kang Yin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"3","key":"5895_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/CAAC.21660.","journal-title":"CA Cancer J Clin"},{"issue":"48","key":"5895_CR2","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/EURHEARTJ\/EHZ766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889\u201397. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ766.","journal-title":"Eur Heart J"},{"issue":"18","key":"5895_CR3","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.18632\/AGING.102301","volume":"11","author":"D Liu","year":"2019","unstructured":"Liu D, Ma Z, Yang J, Zhao M, Ao H, Zheng X, et al. Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study. Aging. 2019;11(18):7948\u201360. https:\/\/doi.org\/10.18632\/AGING.102301.","journal-title":"Aging"},{"key":"5895_CR4","doi-asserted-by":"publisher","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020;10(9). https:\/\/doi.org\/10.1038\/S41408-020-00359-2.","DOI":"10.1038\/S41408-020-00359-2"},{"issue":"9","key":"5895_CR5","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE, Xu W, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 2022;9(9):e670\u20137. https:\/\/doi.org\/10.1016\/S2352-3026(22)00165-X.","journal-title":"Lancet Haematol"},{"key":"5895_CR6","unstructured":"Hong Kong Cancer Registry. Hospital Authority. Available from: https:\/\/www3.ha.org.hk\/cancereg\/.\u00a0Cited 2022 Dec 22."},{"key":"5895_CR7","doi-asserted-by":"publisher","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022;3. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAC244.","DOI":"10.1093\/EURHEARTJ\/EHAC244"},{"issue":"11","key":"5895_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/EJHF.1920","volume":"22","author":"AR Lyon","year":"2020","unstructured":"Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020;22(11):1945\u201360. https:\/\/doi.org\/10.1002\/EJHF.1920.","journal-title":"Eur J Heart Fail"},{"issue":"Supplement 1","key":"5895_CR9","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1182\/BLOOD-2018-99-117959","volume":"132","author":"AS Rosenberg","year":"2018","unstructured":"Rosenberg AS, Li Q, Brunson AM, Tuscano J, Wun T, Keegan THM. Changing Incidence of Major Cardiovascular Events in Multiple Myeloma Patients over Time. Blood. 2018;132(Supplement 1):3598. https:\/\/doi.org\/10.1182\/BLOOD-2018-99-117959.","journal-title":"Blood"},{"key":"5895_CR10","unstructured":"LCQ10. Hospital services in Kowloon Central Cluster. Available from: https:\/\/www.info.gov.hk\/gia\/general\/202407\/17\/P2024071700507.htm.\u00a0Cited 2025 May 2."},{"issue":"5","key":"5895_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/J.1365-2141.2003.04355.X","volume":"121","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Child JA, Anderson K, Barlogie B, Bataille R, Bensinger W, et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749\u201357. https:\/\/doi.org\/10.1046\/J.1365-2141.2003.04355.X.","journal-title":"Br J Haematol"},{"issue":"12","key":"5895_CR12","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"issue":"14","key":"5895_CR13","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/EURHEARTJ\/EHS104","volume":"33","author":"AF Members","year":"2012","unstructured":"Members AF, McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHS104.","journal-title":"Eur Heart J"},{"issue":"9","key":"5895_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 cardiovascular and stroke endpoint definitions for clinical trials. Circulation. 2018;137(9):961\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033502.","journal-title":"Circulation"},{"issue":"3","key":"5895_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/AOS\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk. Annals Stat. 1988;16(3):1141\u201354. https:\/\/doi.org\/10.1214\/AOS\/1176350951.","journal-title":"Annals Stat"},{"issue":"27","key":"5895_CR16","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36(27):4391. https:\/\/doi.org\/10.1002\/sim.7501.","journal-title":"Stat Med"},{"issue":"12","key":"5895_CR17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/17474086.2021.2003704","volume":"14","author":"M Camilli","year":"2021","unstructured":"Camilli M, La Vecchia G, Lillo R, Iannaccone G, Lamendola P, Montone RA, et al. Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances. Expert Rev Hematol. 2021;14(12):1115\u201328. https:\/\/doi.org\/10.1080\/17474086.2021.2003704.","journal-title":"Expert Rev Hematol"},{"key":"5895_CR18","doi-asserted-by":"publisher","unstructured":"Astarita A, Mingrone G, Airale L, Vallelonga F, Covella M, Catarinella C, et al. Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction. Cancers (Basel). 2021;13(7). https:\/\/doi.org\/10.3390\/CANCERS13071631.","DOI":"10.3390\/CANCERS13071631"},{"key":"5895_CR19","doi-asserted-by":"publisher","unstructured":"Yuan S, Zhou JY, Yang BZ, Xie ZL, Zhu TJ, Hu HX, et al. Prediction of cardiovascular adverse events in newly diagnosed multiple myeloma: Development and validation of a risk score prognostic model. Front Oncol. 2023;13. https:\/\/doi.org\/10.3389\/FONC.2023.1043869.","DOI":"10.3389\/FONC.2023.1043869"},{"issue":"11","key":"5895_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1253\/CIRCJ.CJ-19-0426","volume":"83","author":"Y Okura","year":"2019","unstructured":"Okura Y, Ozaki K, Tanaka H, Takenouchi T, Sato N, Minamino T. The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan. Circ J. 2019;83(11):2191\u2013202. https:\/\/doi.org\/10.1253\/CIRCJ.CJ-19-0426.","journal-title":"Circ J"},{"issue":"1","key":"5895_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12885-022-10314-Y\/FIGURES\/3","volume":"22","author":"TL Yeh","year":"2022","unstructured":"Yeh TL, Hsu MS, Hsu HY, Tsai MC, Jhuang JR, Chiang CJ, et al. Risk of cardiovascular diseases in cancer patients: A nationwide representative cohort study in Taiwan. BMC Cancer. 2022;22(1):1\u20138. https:\/\/doi.org\/10.1186\/S12885-022-10314-Y\/FIGURES\/3.","journal-title":"BMC Cancer"},{"key":"5895_CR22","doi-asserted-by":"publisher","unstructured":"Chari A, Mezzi K, Zhu S, Werther W, Felici D, Lyon AR. Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study. BMC Cancer. 2016;16(1). https:\/\/doi.org\/10.1186\/S12885-016-2955-0.","DOI":"10.1186\/S12885-016-2955-0"},{"issue":"10","key":"5895_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","volume":"34","author":"SH Armenian","year":"2016","unstructured":"Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. J Clin Oncol. 2016;34(10):1122. https:\/\/doi.org\/10.1200\/JCO.2015.64.0409.","journal-title":"J Clin Oncol"},{"key":"5895_CR24","doi-asserted-by":"publisher","unstructured":"Waxman AJ, Clasen S, Hwang WT, Garfall A, Vogl DT, Carver J, et al. Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol. 2018;4(3). https:\/\/doi.org\/10.1001\/JAMAONCOL.2017.4519.","DOI":"10.1001\/JAMAONCOL.2017.4519"},{"key":"5895_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2021.01.018","volume":"320","author":"F Shi","year":"2021","unstructured":"Shi F, Sun L, Kaptoge S. Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis. Atherosclerosis. 2021;320:70\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.01.018.","journal-title":"Atherosclerosis"},{"issue":"Supplement1","key":"5895_CR26","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1182\/BLOOD-2019-127680","volume":"134","author":"AC Oliver","year":"2019","unstructured":"Oliver AC, Superchi R, Federico S, Matilde C, Silvana J, Errecarte C, et al. Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity. Blood. 2019;134(Supplement1):5688. https:\/\/doi.org\/10.1182\/BLOOD-2019-127680.","journal-title":"Blood"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05895-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:28:48Z","timestamp":1781134128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05895-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5895"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05895-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Central Institutional Review Board of Hospital Authority Head Office Steering Committee on Research Ethics approved the study (Ref: CIRB-2025-119-3). The need for informed consent was waived by the Central Institutional Review Board of Hospital Authority Head Office Steering Committee on Research Ethics. This study conformed with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}